Market Eyes LiveABBVIE INC. (ABBV) Stock Rating
MELANY's data-driven read on ABBVIE INC. · Pharmaceutical Preparations.
73/100
BUY
···
Live price
AbbVie is a pharmaceutical firm with strong exposure to immunology (Humira, Skyrizi, and Rinvoq) and oncology (Imbruvica and Venclexta), spun off from Abbott in early 2013. Its 2020 acquisition of Allergan added products and drugs in aesthetics including Botox, and its 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) further supplement its portfolio.
Entry zone, stop-loss, price targets, and live alerts unlock when you sign up. No card required.